Pursue proven alternatives
doi: 10.1038/emboj.2012.170 45
The primary structural difference, tirzepatide dual GIP/GLP-1 activity versus semaglutide single GLP-1 activity, does not significantly affect storage stability
Other notable adverse effects include injection site reactions (typically mild), gallbladder problems including cholelithiasis, acute kidney injury (particularly with severe dehydration from gastrointestinal side effects), and hypersensitivity reactions including anaphylaxis and angioedema
However, Ozempic doses and clinical goals are designed around diabetes treatment
After matching over 283,000 patients and controlling for relevant risk factors, researchers found that people treated with tirzepatide did not have a higher risk of thyroid cancer